While the drug has not been investigated in a head-to-head weight loss trial, data suggest that Lilly's Zepbound is more effective than Boehringer's survodutide.
The post Boehringer’s weight loss jab as good as Wegovy but not Zepbound appeared first on Clinical Trials Arena.